Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1825 of 3173 entries
View as:

A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)

Phase: N/A Priority: Normal
NCT ID: NCT01934738 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

Safety and Tolerability of PF-06818883 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03020784 Org: User:
Start: 11/11/16 End: 06/13/17 Due: 06/13/18

Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea

Phase: N/A Priority: Normal
NCT ID: NCT05022563 Org: User:
Start: 08/31/21 End: 09/30/21 Due: 09/30/22

Study Evaluating Pharmacovigilance Of Refacto AF

Phase: N/A Priority: Normal
NCT ID: NCT00895037 Org: User:
Start: 07/17/09 End: 10/19/16 Due: 10/19/17

A Global Active Surveillance for Community Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00929721 Org: User:
Start: 12/31/09 End: 02/29/12 Due: 02/28/13

To Test The Relative Bioavailability Of PF-04191834 When Dosed As An Immediate Release Tablet Compared With Solution Following Single And Multiple Dosing

Phase: N/A Priority: Normal
NCT ID: NCT01064804 Org: User:
Start: 09/30/09 End: 11/30/09 Due: 11/30/10

Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00324116 Org: User:
Start: 07/31/06 End: 08/31/08 Due: 08/31/09

A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00636064 Org: User:
Start: 01/31/03 End: 01/31/04 Due: 01/31/05

A Study to Understand How the Study Medicine (PF-07081532) is Processed and Eliminated in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT05652647 Org: User:
Start: 12/21/22 End: 03/15/23 Due: 03/15/24

To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity

Phase: N/A Priority: Normal
NCT ID: NCT01165736 Org: User:
Start: 07/31/10 End: 08/31/10 Due: 08/31/11

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders

Phase: N/A Priority: Normal
NCT ID: NCT01456936 Org: User:
Start: 11/30/11 End: 01/31/15 Due: 01/31/16

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

Phase: N/A Priority: Normal
NCT ID: NCT04842604 Org: User:
Start: 05/17/21 End: 12/02/22 Due: 12/02/23

Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00430300 Org: User:
Start: 01/31/07 End: 07/31/08 Due: 07/31/09

A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01121549 Org: User:
Start: 02/28/10 End: 12/31/12 Due: 12/31/13

Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America

Phase: N/A Priority: Normal
NCT ID: NCT00084227 Org: User:
Start: 07/31/04 End: 07/31/05 Due: 07/31/06

Treatment of Pediatric Hypertension With Altace Trial

Phase: N/A Priority: Normal
NCT ID: NCT00044265 Org: User:
Start: 07/31/02 End: 11/30/04 Due: 11/30/05

A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT

Phase: N/A Priority: Normal
NCT ID: NCT04193436 Org: User:
Start: 01/21/20 End: 07/09/21 Due: 07/09/22

A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

Phase: N/A Priority: Normal
NCT ID: NCT00911937 Org: User:
Start: 08/31/09 End: 09/30/11 Due: 09/30/12

This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00943735 Org: User:
Start: 07/31/09 End: 11/30/10 Due: 11/30/11

Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01565928 Org: User:
Start: 01/24/12 End: 02/26/18 Due: 02/26/19

A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals

Phase: N/A Priority: Normal
NCT ID: NCT01089738 Org: User:
Start: 11/01/10 End: 04/25/11 Due: 04/25/12

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00980655 Org: User:
Start: 01/18/10 End: 05/16/13 Due: 05/16/14

Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT00318994 Org: User:
Start: 02/28/02 End: 05/31/07 Due: 05/31/08

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00755196 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

Phase: N/A Priority: Normal
NCT ID: NCT00988624 Org: User:
Start: 10/31/09 End: 12/31/09 Due: 12/31/10